Antifungal hypersensitivity reactions and cross-reactivity patterns
Authors:
- 22 October 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 34 (6) , 559-572
Abstract
Purpose of review: The goal of this article is to provide an updated understanding and evidence-based approach where possible for antifungal hypersensitivity. This includes recognition of clinical phenotype, implications for cross-reactivity and diagnostic, and management strategy for immediate and delayed hypersensitivity reactions. Recent findings: Antifungal hypersensitivity reactions can be classified according to their latency (immediate or delayed) and clinical phenotype. The majority of the cases described in the literature are delayed T-cell mediated reactions of various severities but immediate reactions consistent with non-Immunoglobulin E (IgE)-mediated mast cell activation and IgE-mediated reactions have also been described. Ancillary information such as skin testing, drug challenge and ex vivo experimental approaches can aid causality assessments and inform antifungal class cross-reactivity, which help optimize antifungal prescribing and stewardship. Summary: This review will update the clinician on mechanisms of drug hypersensitivity as well as providing a structured approach to the recognition, diagnosis and management of antifungal hypersensitivity reaction.Keywords
This publication has 92 references indexed in Scilit:
- The skin prick test – European standardsClinical and Translational Allergy, 2013
- Toxic epidermal necrolysis caused by fluconazole in a patient with human immunodeficiency virus infectionJournal of Pharmacology and Pharmacotherapeutics, 2012
- Fluconazole induced toxic epidermal necrolysis: a case reportCases Journal, 2009
- Acute generalized exanthematous pustulosis induced by itraconazole: an immunological approachClinical and Experimental Dermatology, 2009
- Lack of Allergic Cross-Reactivity between Fluconazole and VoriconazoleAntimicrobial Agents and Chemotherapy, 2009
- Fixed drug eruption resulting from fluconazole use: a case reportJournal of Medical Case Reports, 2009
- Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test resultJournal of the American Academy of Dermatology, 1997
- A study of 72 patients with contact allergy to tioconazoleBritish Journal of Dermatology, 1996
- Itraconazole-induced acute generalized exanthemic pustulosisJournal of the American Academy of Dermatology, 1995
- Toxic epidermal necrolysis from griseofulvinJournal of the American Academy of Dermatology, 1988